Mealey's (January 9, 2023, 1:13 PM EST) -- WILMINGTON, Del. — A request by a generic drugmaker for judgment on the pleadings that “third wave” patent infringement claims by the maker of a brand name hypertension drug are precluded by prior judgments in the parties’ first and second waves of litigation was denied Jan. 6 by a federal judge visiting in the U.S. District Court for the District of Delaware....